Furthermore, SOX2 expression has been associated with early events of cervical carcinogenesis [49], since it is highly expressed in premalignant lesions, as well as in cervical cancer, while its expression is low in normal cervical epithelium. This evidence concerns the gene SOX2 and cervical carcinoma.